Skip to main content
Watch Insiders

Corporate insider profile

Fred Aslan Insider Trades

Latest reported as Chief Executive Officer of Artiva Biotherapeutics, Inc. (ARTV).

Purchase filings
0
Reported companies
1
Net open-market value
-$1,781,098.18
Latest transaction
Oct 6, 2026

Affiliated corporations

Reported company relationships

ARTVLatest reported

Artiva Biotherapeutics, Inc.

Chief Executive Officer

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Oct 6, 2026Artiva Biotherapeutics, Inc. (ARTV)Chief Executive OfficerSale23,463$7.20$168,880
Oct 5, 2026Artiva Biotherapeutics, Inc. (ARTV)Chief Executive OfficerSale61,696$6.84$421,828
Sep 8, 2026Artiva Biotherapeutics, Inc. (ARTV)Chief Executive OfficerSale23,429$10.92$255,746
Sep 3, 2026Artiva Biotherapeutics, Inc. (ARTV)Chief Executive OfficerSale61,888$11.16$690,392
May 19, 2026Artiva Biotherapeutics, Inc. (ARTV)Chief Executive OfficerSale27,116$9.01$244,253